Updated Jul 16, 2026
Graves Adrienne L has filed 4 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $31K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | OCUL | OCULAR THERAPEUTIX, INC | A — Grant or award | 14.0K | $0.00 | |
| 2026-05-19 | HROW | HARROW, INC. | P — Open-market purchase | 1.0K | $31.07 | $31K |
| 2026-04-22 | IRD | Opus Genetics, Inc. | A — Grant or award | 24.4K | $0.00 | |
| 2026-01-05 | IRD | Opus Genetics, Inc. | A — Grant or award | 23.6K | — | |
| 2025-04-30 | IRD | Opus Genetics, Inc. | A — Grant or award | 79.5K | $0.00 |
Graves Adrienne L is a corporate insider — currently tracked as Director of HARROW, INC. (HROW). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 1 open-market purchases ($31K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Graves Adrienne L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.